HIRONIC introduced its products at conferences and exhibitions held in Seoul and Busan.


The HIRONIC booth at the 2026 Fall Conference of the Korean Society of Dermatology, Obesity and Plastic Surgery, and the HIRONIC Korea booth at “Beauty & Derma Busan,” a special exhibition at KIMES Busan 2026. HIRONIC

The HIRONIC booth at the 2026 Fall Conference of the Korean Society of Dermatology, Obesity and Plastic Surgery, and the HIRONIC Korea booth at “Beauty & Derma Busan,” a special exhibition at KIMES Busan 2026. HIRONIC

View original image

According to HIRONIC on October 28, the company exhibited its microwave energy-based medical device, Miglow, and showcased its key technologies and features at the 2026 Fall Conference of the Korean Society of Dermatology, Obesity and Plastic Surgery, held at Hall E of COEX in Seoul. Miglow is a medical device that uses 2.45-gigahertz (GHz) microwave energy and Focused Intensive Microwave (FIM) technology.


In Busan, HIRONIC took part in the “Beauty & Derma Busan” special exhibition at KIMES Busan 2026, held at Exhibition Center 1 of BEXCO. At the event, held in conjunction with the 50th Fall Conference of the Korean Academy of Aesthetic Medicine, the company explained key features of its Synerjet Pro, including its microjet-based drug delivery technology, and held product consultations for medical professionals and industry representatives. Synerjet Pro is a needle-free injector medical device that incorporates three technologies: microjet, low-frequency stimulation using an electroporation (EP) tip, and plasma.



“Through these events, we introduced the technologies and features of Miglow and Synerjet Pro to medical professionals in Seoul and Busan,” a HIRONIC representative said. “We will continue to strengthen communication with medical professionals and expand our customer reach through academic conferences and exhibitions both in Korea and overseas.”


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing